Filing Details
- Accession Number:
- 0001415889-21-001613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-23 08:06:32
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-23 08:06:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1134765 | Charlie's Holdings Inc. | CHUC | Medicinal Chemicals & Botanical Products (2833) | 841575085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1775562 | Brandon Stump | C/O Charlie'S Holdings, Inc. 1007 Brioso Drive Costa Mesa CA 92627 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-15 | 9,285,426,712 | $0.00 | 93,792,177 | No | 4 | G | Direct | |
Common Stock | Acquisiton | 2021-02-15 | 9,285,426,712 | $0.00 | 9,285,426,712 | No | 4 | G | Indirect | By the Brandon Stump Legacy Trust |
Common Stock | Disposition | 2021-03-19 | 3,150,000,013 | $0.00 | 6,135,426,699 | No | 4 | S | Indirect | By the Brandon Stump Legacy Trust |
Common Stock | Acquisiton | 2021-03-22 | 246,189,918 | $0.01 | 6,381,616,617 | No | 4 | A | Indirect | By the Brandon Stump Legacy Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | G | Direct | |
No | 4 | G | Indirect | By the Brandon Stump Legacy Trust |
No | 4 | S | Indirect | By the Brandon Stump Legacy Trust |
No | 4 | A | Indirect | By the Brandon Stump Legacy Trust |
Footnotes
- On February 15, 2021, the Reporting Person transferred 9,285,426,712 shares of common stock to the Brandon Stump Legacy Trust, of which the reporting person is trustee. The Reporting Person and immediate family members are the sole beneficiaries of the trust.
- The shares were sold in a private transaction consummated on March 19, 2021 at a price of $0.000833 per share.
- The shares of common stock were purchased from the Issuer in a transaction approved by the Issuer's Board of Directors in accordance with Rule 16b-3(d)(1) of the Exchange Act (the "Act"), which purchase is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder.